Page 27 - Read Online
P. 27

Page 2 of 5         De Alcantara Filho et al. J Cancer Metastasis Treat 2019;5:2  I  http://dx.doi.org/10.20517/2394-4722.2018.62

                                A                             B



















                 Figure 1. A: Tumor magnetic resonance imaging, axial; B: intramammary sentinel lymph node magnetic resonance imaging, axial view


               CASE REPORT
               A 44-year-old, post-menopausal female with a mammogram showing a partially defined lump of the right
               breast. Breast ultrasound (US) showed a circumscribed hypoechoic lesion, 1.4 × 1.1 cm, 3.8 cm away from
               the areolar complex, and also an adjacent hypoechoic microlobulated lesion of 1.4 × 1.2 × 1.4 cm, both in the
               outer quadrants of the right breast. US-guided core-needle biopsy of the lesion revealed a high grade invasive
               ductal carcinoma (IDC), luminal B (estrogen receptor 30%, progesterone receptor and human epidermal
               growth factor receptor type 2 negative, and Ki-67 of 80%).


               Magnetic resonance imaging (MRI) showed a mass with spiculated contours at early and heterogeneous
               post-contrast enhancement in the junction of the outer quadrants of the right breast, measuring 1.8 × 1.6 ×
               1.5 cm [Figure 1A and B]. In addition, a circumscribed oval mass at early and homogeneous post-contrast
               enhancement, in lower inner quadrant, measuring 9 × 5 × 5 mm and in close contact with the pectoralis
               muscle, which seemed to correspond to an IMLN. Second-look US was performed directly to this lymph
               node, which revealed a suspicious cortical thickening and a decreased hilum. A breast conserving surgery
               of the index lesion, plus radioguided occult lesion localization of the suspicious lesion in the lower inner
               quadrant and sentinel lymph node biopsy (SLNB), were performed. The pathology report of the lesions
               identified an IDC, no special type, histology and nuclear grade III and ductal carcinoma in situ associated.
               Three axillary sentinel lymph nodes (SLNs) were free of metastases, however the suspected lesion in the
               lower inner quadrant resulted in 3 IMLNs, all affected by cancer metastases with ECE [Figure 2A and B].

               Published literature for IMLNs does not mention capsular leakage, thus, there is no consensus for the best
               treatment. Pathologists admitted margins in lymph nodes were not frozen, which did not make it feasible
               to know if the margins of the additional lesions were disease free. Multidisciplinary recommendation was
               mastectomy without axillary lymph node dissection (ALND) and immediate breast reconstruction with
               implants, which was performed two weeks after the patient’s consent in regards to the unknown probability
               of further disease in the IMLNs. Pathology report revealed no evidence of malignancy. The patient
               underwent 4 cycles of anthracycline + cyclophosphamide followed by 12 cycles of taxanes and breast +
               axillary, internal mammary and supraclavicullar drainage chain radiation therapy + tamoxifen. After 2 years
               of follow up, the patient suddenly developed axillary pain and fistulization accompanied by fever, and sought
               the emergency room immediately [Figure 3A]. US and breast MRI showed an axillary lymph node with
               high T2 signaling, measuring 4.0 × 3.6 cm in deep contact with pectoralis muscle and a circumscribed oval
               mass at early and homogeneous post-contrast enhancement, located in the level 2 of the axilla, measuring
               1.0 × 0.9 cm.
   22   23   24   25   26   27   28   29   30   31   32